Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
06 May 2016 EMA Recommends Granting a Marketing Authorisation for Lutetium (177 Lu) Chloride Imaging - Endocrine cancers
04 May 2016 EMA Recommends Extending the Authorised Indications for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
03 May 2016 EMA Adopts a New Indication for Everolimus Endocrine cancers - Anticancer agents & Biologic therapy
02 May 2016 EMA Adopts a New Indication for Bevacizumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
26 Apr 2016 Mucinous Colorectal Cancer Pathology/Molecular biology - Gastrointestinal cancers
25 Apr 2016 Integrating Patients’ Views in Clinical Studies of Anticancer Medicines Anticancer agents & Biologic therapy
19 Apr 2016 Microbiota in Colorectal Cancer Basic science - Gastrointestinal cancers
18 Apr 2016 FDA Approves Venetoclax for CLL in Patients With 17p Deletion Who Have Been Treated With at Least One Prior Therapy Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Osimertinib Combined With Durvalumab in EGFR-mutant Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Updates from CheckMate 063 and 017 Trials Confirm Nivolumab Efficacy in Patients with Advanced Platinum-Refractory Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
15 Apr 2016 ELCC 2016 News: Novel Durvalumab plus Gefitinitib Shows Promise in EGFR Mutated NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Comprehensive Molecular Profiling Shows Disparity Between Primary NSCLC Tumours and Metastases Pathology/Molecular biology - Lung and other thoracic tumours
15 Apr 2016 ELCC 2016 Press Release: Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy Lung and other thoracic tumours - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 Press Release: Studies Confirm Benefit of Plasma Genotyping to Predict Treatment Benefit in Patients with Non-Small-Cell Lung Cancer Lung and other thoracic tumours
14 Apr 2016 ELCC 2016 News: Elderly Patients with Malignant Pleural Mesothelioma Should Not Be Excluded from Extended Pleurectomy Decortication Lung and other thoracic tumours